Chinese herbal medicine will accelerate to enter the global medical insurance system

From November 30 to December 2, the fifth annual meeting of the International Cooperation Organization for plant drug regulation and supervision was held in Guangzhou The meeting was attended by 40 officials and experts from 16 international organizations, countries and regions, including the World Health Organization, the European drug administration, ASEAN, China, Hong Kong, Brazil, Canada, Ghana, India, Singapore and South Africa, to jointly promote the safe use of traditional botanical drugs in the world and ensure and promote global public health Safety Zhang Qi, who coordinator of traditional medicine, presided over the meeting, and Chen Yuansheng, director of Guangdong food and drug administration, gave a welcome speech As one of the important topics of this meeting, Zhang Wei, director of SFDA registration department, and amarty, deputy director of Ghana drug administration were nominated as the president of this meeting At the meeting, seven working groups under the International Cooperation Organization for plant drug regulation and supervision reported and discussed the identification of drug adulteration, quality control of traditional Chinese medicine and patent medicine, control research, plant drug monitoring, research and development, patient and doctor education, information sharing and communication, etc Many countries have formulated or started to formulate relevant laws and regulations, and gradually carry out effective supervision under the framework of laws and regulations At the same time, the quality, safety and rational use of these botanical drugs have also increased capital investment, supervision and international cooperation To strengthen international regulatory cooperation, it is reported that the International Cooperation Organization for plant drug regulation and regulation is a cooperative organization initiated by the Technical Cooperation Department of essential drugs and traditional drugs of the World Health Organization and relevant governments Its members are national or regional drug supervision and administration institutions, striving to protect and promote public health and safety through the improvement of plant drug regulatory regulations Since the first meeting of the International Cooperation Organization for plant drug regulation and supervision was hosted by SFDA in Beijing in October 2006, the organization has been growing Last year, it attracted Brunei to join in At present, 21 countries and regions, as well as three regional international organizations, have become members of the international cooperation organization for plant drug regulation and supervision, and built a global cooperation platform for plant drug regulation At present, the World Health Organization has set up 20 cooperation centers, and another five cooperation centers are also under planning The international scale and influence of the International Cooperation Organization for plant drug regulation and supervision are gradually expanding Since the fourth annual meeting of the international organization for cooperation on regulations and supervision of botanical drugs, international supervision cooperation and information sharing of traditional botanical drugs have been further strengthened, including the establishment of databases, the publication of training materials, and the help of some countries to establish a standard system for medicinal materials Next year, in addition to continuing to promote the existing work, the International Cooperation Organization for regulations and supervision of botanical drugs will conduct research on the legal system guarantee of traditional botanical drugs in its member countries, formulate a global strategy for traditional drugs, strengthen the supervision of traditional drugs at the national level, support and issue policies, provide services for member countries, and carry out professional and technical committee activities Or hold an international forum to provide case demonstration, promote experience and strengthen dialogue and exchange at the policy level "Globalization has brought us great convenience as well as new challenges," Zhang said Drugs produced in one country may reach patients in any country in the world, and the R & D, production and supply of drugs may also be completed by different countries The supply chain is not only built in one country or one continent, so the regulation of drugs cannot rely on one country, and global cooperation becomes necessary " The doping problem that plagues the promotion of traditional botanical drugs in the global scope has become one of the focuses of the delegates at the meeting Countries attach great importance to the material detection of traditional botanical drugs without prior indication, including the banned western medicine ingredients, pesticides, heavy metal residues and other situations, and hope to strengthen experience exchange and cooperation At this meeting, Lin Ruichao, chief scientist of CFDA, introduced the most commonly used and advanced detection technologies (including microscope analysis, physical and chemical analysis, chromatographic analysis, spectral determination, fingerprint determination, etc.) and the research of reference materials to member countries In addition to technical testing, delegates also called for the establishment of a pre - or post market police mechanism for traditional botanical drugs Representatives from Singapore gave a group of examples, including the discovery of phenolphthalein and sibutramine from Baoji pill's light packed capsules, as well as the gastrointestinal and oral side effects of qingxinbaoji tablet due to doping problems, which were found through post market police monitoring The quality control of traditional Chinese medicine in China has included the introduction of the source of traditional Chinese medicine, the properties of the finished product, the main functions, taboos and the production process, especially the introduction of the production process of traditional Chinese medicine injection However, in many countries, traditional botanical drugs are not managed by classification, but by OTC Therefore, Lin Ruichao suggested that the supervision of traditional botanical drugs in relevant countries could involve more information Accelerate access to the global health care system In addition to strengthening international regulatory cooperation and information sharing, the two major tasks of the International Cooperation Organization for plant drug regulation and regulation next year are to promote the application of traditional drugs in basic medical care, promote the global strategy of traditional drugs from the political and economic aspects, and accelerate the process of integrating traditional drugs into the six major sectors of the world's health system Last year, the International Cooperation Organization for plant drug regulation and supervision launched the second survey on policies and services of traditional drugs More than 100 countries participated in the questionnaire survey to find out the use and popularization of traditional plant drugs in the global health system Information has been collected to the World Health Organization The relevant survey report is expected to be published next year At present, China, Japan, Myanmar, Mongolia and other Asian countries have gained good experience in the application of botanical medicine in basic medical treatment, including the promotion of traditional Chinese massage, acupuncture and moxibustion technology, etc The International Cooperation Organization for the regulation and supervision of botanical medicine hopes to promote the model experience of the above countries around the world Therefore, the International Cooperation Organization for plant drug regulation and supervision will improve the management standards of traditional drugs from technicians, diagnostic methods, intellectual property rights and other aspects, so as to lay the foundation for the next promotion and use Some countries that regard traditional plant medicine as health care product management are also constantly standardizing relevant management, including the specification of function declaration and label identification In order to shorten the registration time of related drugs, Canada and other countries have established a pre licensing information mechanism to simplify the registration and approval process At present, the World Health Organization also cooperates with two organizations related to drug classification and quality control in the field of traditional botanical drugs The purpose is to promote and regulate the international classification and branches of traditional drugs, hoping to include traditional drugs in ICD-11 According to the information revealed at this conference, China, India and other countries have included traditional medicine in the basic medical security system Participants believed that the promotion of these experiences would provide reference for other countries ASEAN has also set up an expert committee on the development of traditional medical standards to remove technical barriers for traditional drugs to enter the medical insurance system of member countries At present, some traditional drugs and some substitutes and supplements have been listed in the health care system of ASEAN.